Eli Lilly And Company (CH:LLY)
NYSE:LLY
Total Valuation
Eli Lilly & Co has a market cap or net worth of CHF839.00B. The enterprise value is CHF1.09T.
Market CapCHF839.00B
Enterprise ValueCHF1.09T
Share Statistics
Eli Lilly & Co has 941,741,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding941,741,400
Owned by Insiders9.91%
Owned by Institutions26.77%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 30.20%.
Return on Equity (ROE)0.78
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)30.20%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee1.39M
Profits Per Employee439.15K
Employee Count47,000
Asset Turnover0.58
Inventory Turnover0.77
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 39.1. Eli Lilly & Co’s PEG ratio is 0.49.
PE Ratio39.1
PS Ratio14.81
PB Ratio36.37
Price to Fair Value36.37
Price to FCF107.56
Price to Operating Cash Flow48.35
PEG Ratio0.49
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of 65.18B and earned 20.64B in profits. Earnings per share was 23.00.
Revenue65.18B
Gross Profit54.62B
Operating Income29.70B
Pretax Income25.73B
Net Income20.64B
EBITDA27.94B
Earnings Per Share (EPS)23.00
Cash Flow
In the last 12 months, operating cash flow was 20.48B and capital expenditures -6.90B, giving a free cash flow of 13.58B billion.
Operating Cash Flow20.48B
Free Cash Flow13.58B
Free Cash Flow per Share14.42
Dividends & Yields
Eli Lilly & Co pays an annual dividend of CHF1.362, resulting in a dividend yield of 0.6%
Dividend Per ShareCHF1.362
Dividend Yield0.6%
Payout Ratio27.11%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change44.82%
50-Day Moving Average800.78
200-Day Moving Average761.48
Relative Strength Index (RSI)58.02
Average Volume (3m)3.00
Important Dates
Eli Lilly & Co upcoming earnings date is Aug 5, 2026, Before Open (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Eli Lilly & Co as a current ratio of 1.58, with Debt / Equity ratio of 139.02%
Current Ratio1.58
Quick Ratio1.19
Debt to Market Cap0.04
Net Debt to EBITDA1.27
Interest Coverage Ratio37.34
Taxes
In the past 12 months, Eli Lilly & Co has paid 5.09B in taxes.
Income Tax5.09B
Effective Tax Rate0.20
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 35.81, with an EV/FCF ratio of 111.50.
EV to Sales15.35
EV to EBITDA35.81
EV to Free Cash Flow111.50
EV to Operating Cash Flow59.50
Balance Sheet
Eli Lilly & Co has CHF5.28B in cash and marketable securities with CHF43.37B in debt, giving a net cash position of -CHF38.09B billion.
Cash & Marketable SecuritiesCHF5.28B
Total DebtCHF43.37B
Net Cash-CHF38.09B
Net Cash Per Share-CHF40.44
Tangible Book Value Per ShareCHF15.72
Margins
Gross margin is 83.51%, with operating margin of 45.56%, and net profit margin of 31.66%.
Gross Margin83.51%
Operating Margin45.56%
Pretax Margin39.48%
Net Profit Margin31.66%
EBITDA Margin42.86%
EBIT Margin40.46%
Analyst Forecast
The average price target for Eli Lilly & Co is CHF1,045.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetCHF1,045.71
Price Target Upside45.24% Upside
Analyst ConsensusStrong Buy
Analyst Count22
Revenue Growth Forecast33.22%
EPS Growth Forecast107.22%